ABVC BioPharma auditor WWC P.C. declines renewal; Simon & Edward LLP appointed

ABVC BIOPHARMA, INC.

WWC agreed not to renew engagement effective Oct 10, 2024; Board approved non-renewal on Oct 17.
Board approved engagement of Simon & Edward, LLP as new independent registered public accounting firm on Oct 17.
WWC's reports for FY2022-2023 and interim Jun 2024 had no adverse opinion except a going concern paragraph.
No disagreements or reportable events between Company and WWC during the relevant periods.
Prior consultations with S&E regarding accounting principles or disagreements did not occur.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.